Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Luigi Meroni

Showing results (51-60 of 276) with videos related to

Pageof 28
Sort By:
Seminars in Arthritis and Rheumatism|December 17, 2013
The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrollment: data from a systematic review and meta-analysisEnnio Giulio Favalli, Francesca Pregnolato, Martina Biggioggero, et al.
Clinical Reviews in Allergy & Immunology|July 24, 2017
Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive ReviewMassimo Cugno, Roberta Gualtierotti, Pier Luigi Meroni, et al.
Rheumatology (Oxford, England)|April 15, 2014
Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategiesEnnio Giulio Favalli, Martina Biggioggero, Antonio Marchesoni, et al.
Rheumatology (Oxford, England)|February 6, 2024
Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?Elena Raschi, Maria Orietta Borghi, Francesco Tedesco, et al.
Seminars in Thrombosis and Hemostasis|August 5, 2017
Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic ReviewMassimo Radin, Irene Cecchi, Dario Roccatello, et al.
Immunobiology|March 18, 2003
Endothelium as a target for antiphospholipid antibodiesPiersandro Riboldi, Maria Gerosa, Elena Raschi, et al.
Ocular Immunology and Inflammation|October 23, 2013
Long-term treatment with golimumab for severe uveitisElisabetta Miserocchi, Giulio Modorati, Irene Pontikaki, et al.
Autoimmunity Reviews|November 1, 2011
Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis: "Pros" and "Cons"Fulvia Ceccarelli, Cecilia Chighizola, Guido Finazzi, et al.
Frontiers in Pharmacology|June 14, 2021
Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the RoadAsmaa Beltagy, Azin Aghamajidi, Laura Trespidi, et al.
Nature Reviews. Rheumatology|November 6, 2020
Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseasesXavier Bossuyt, Ellen De Langhe, Maria Orietta Borghi, et al.
Pageof 28

Showing results (51-60 of 276) with videos related to

Sort By:
Pageof 28
Seminars in Arthritis and Rheumatism|December 17, 2013
The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrollment: data from a systematic review and meta-analysisEnnio Giulio Favalli, Francesca Pregnolato, Martina Biggioggero, et al.
Clinical Reviews in Allergy & Immunology|July 24, 2017
Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive ReviewMassimo Cugno, Roberta Gualtierotti, Pier Luigi Meroni, et al.
Rheumatology (Oxford, England)|April 15, 2014
Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategiesEnnio Giulio Favalli, Martina Biggioggero, Antonio Marchesoni, et al.
Rheumatology (Oxford, England)|February 6, 2024
Antiphospholipid syndrome pathogenesis in 2023: an update of new mechanisms or just a reconsideration of the old ones?Elena Raschi, Maria Orietta Borghi, Francesco Tedesco, et al.
Seminars in Thrombosis and Hemostasis|August 5, 2017
Prevalence and Thrombotic Risk Assessment of Anti-β2 Glycoprotein I Domain I Antibodies: A Systematic ReviewMassimo Radin, Irene Cecchi, Dario Roccatello, et al.
Immunobiology|March 18, 2003
Endothelium as a target for antiphospholipid antibodiesPiersandro Riboldi, Maria Gerosa, Elena Raschi, et al.
Ocular Immunology and Inflammation|October 23, 2013
Long-term treatment with golimumab for severe uveitisElisabetta Miserocchi, Giulio Modorati, Irene Pontikaki, et al.
Autoimmunity Reviews|November 1, 2011
Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis: "Pros" and "Cons"Fulvia Ceccarelli, Cecilia Chighizola, Guido Finazzi, et al.
Frontiers in Pharmacology|June 14, 2021
Biologics During Pregnancy and Breastfeeding Among Women With Rheumatic Diseases: Safety Clinical Evidence on the RoadAsmaa Beltagy, Azin Aghamajidi, Laura Trespidi, et al.
Nature Reviews. Rheumatology|November 6, 2020
Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseasesXavier Bossuyt, Ellen De Langhe, Maria Orietta Borghi, et al.
Pageof 28